{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:05:58Z","timestamp":1761743158620},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn J Ophthalmol"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1007\/s10384-008-0579-x","type":"journal-article","created":{"date-parts":[[2008,12,16]],"date-time":"2008-12-16T20:51:53Z","timestamp":1229460713000},"page":"475-482","source":"Crossref","is-referenced-by-count":7,"title":["Using frequency-doubling perimetry to detect optic neuropathy in patients with Graves\u2019 orbitopathy"],"prefix":"10.1007","volume":"52","author":[{"given":"M\u00e1rio L. R.","family":"Monteiro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9 L. F.","family":"Portes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederico C.","family":"Moura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dina B. W.","family":"Regensteiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,11,1]]},"reference":[{"key":"579_CR1","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/S0161-6420(88)32978-7","volume":"95","author":"J.M. Neigel","year":"1988","unstructured":"Neigel JM, Rootman J, Belkin RI, et al. Dysthyroid optic neuropathy. The crowded orbital apex syndrome. Ophthalmology 1988;95:1515\u20131521.","journal-title":"Ophthalmology"},{"key":"579_CR2","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1016\/S0161-6420(91)32114-6","volume":"98","author":"M. Kazim","year":"1991","unstructured":"Kazim M, Trokel S, Moore S. Treatment of acute Graves orbitopathy. Ophthalmology 1991;98:1443\u20131448.","journal-title":"Ophthalmology"},{"key":"579_CR3","first-page":"1","volume-title":"Automated perimetry","author":"D. Anderson","year":"1999","unstructured":"Anderson D, Patella V. Automated perimetry, 2nd ed. St Louis: Mosby; 1999. p. 1\u2013363.","edition":"2nd ed."},{"key":"579_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0161-6420(95)31060-3","volume":"102","author":"J. Katz","year":"1995","unstructured":"Katz J, Tielsch JM, Quigley HA, Sommer A. Automated perimetry detects visual field loss before manual Goldmann perimetry. Ophthalmology 1995;102:21\u201326.","journal-title":"Ophthalmology"},{"key":"579_CR5","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1097\/00041327-199906000-00004","volume":"19","author":"J.M. Khoury","year":"1999","unstructured":"Khoury JM, Donahue SP, Lavin PJ, Tsai JC. Comparison of 24-2 and 30-2 perimetry in glaucomatous and nonglaucomatous optic neuropathies. J Neuroophthalmol 1999;19:100\u2013108.","journal-title":"J Neuroophthalmol"},{"key":"579_CR6","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/00041327-200403000-00011","volume":"24","author":"M. Wall","year":"2004","unstructured":"Wall M. What\u2019s new in perimetry. J Neuroophthalmol 2004;24:46\u201355.","journal-title":"J Neuroophthalmol"},{"key":"579_CR7","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1034\/j.1600-0420.1998.760208.x","volume":"76","author":"B. Bengtsson","year":"1998","unstructured":"Bengtsson B, Heijl A, Olsson J. Evaluation of a new threshold visual field strategy, SITA, in normal subjects. Swedish Interactive Thresholding Algorithm. Acta Ophthalmol Scand 1998;76:165\u2013169.","journal-title":"Acta Ophthalmol Scand"},{"key":"579_CR8","first-page":"413","volume":"38","author":"C.A. Johnson","year":"1997","unstructured":"Johnson CA, Samuels SJ. Screening for glaucomatous visual field loss with frequency-doubling perimetry. Invest Ophthalmol Vis Sci 1997;38:413\u2013425.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"579_CR9","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S0002-9394(98)00046-4","volume":"125","author":"H.A. Quigley","year":"1998","unstructured":"Quigley HA. Identification of glaucoma-related visual field abnormality with the screening protocol of frequency doubling technology. Am J Ophthalmol 1998;125:819\u2013829.","journal-title":"Am J Ophthalmol"},{"key":"579_CR10","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1364\/JOSA.71.001051","volume":"71","author":"D.H. Kelly","year":"1981","unstructured":"Kelly DH. Nonlinear visual responses to flickering sinusoidal gratings. J Opt Soc Am 1981;71:1051\u20131055.","journal-title":"J Opt Soc Am"},{"key":"579_CR11","first-page":"2558","volume":"41","author":"N. Fujimoto","year":"2000","unstructured":"Fujimoto N, Adachi-Usami E. Frequency doubling perimetry in resolved optic neuritis. Invest Ophthalmol Vis Sci 2000;41:2558\u20132560.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"579_CR12","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/S0002-9394(01)00837-6","volume":"131","author":"D. Thomas","year":"2001","unstructured":"Thomas D, Thomas R, Muliyil JP, George R. Role of frequency doubling perimetry in detecting neuro-ophthalmic visual field defects. Am J Ophthalmol 2001;131:734\u2013741.","journal-title":"Am J Ophthalmol"},{"key":"579_CR13","first-page":"1277","volume":"43","author":"M. Wall","year":"2002","unstructured":"Wall M, Neahring RK, Woodward KR. Sensitivity and specificity of frequency doubling perimetry in neuro-ophthalmic disorders: a comparison with conventional automated perimetry. Invest Ophthalmol Vis Sci 2002;43:1277\u20131283.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"579_CR14","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/S0002-9394(14)72787-4","volume":"119","author":"G.B. Bartley","year":"1995","unstructured":"Bartley GB, Gorman CA. Diagnostic criteria for Graves\u2019 ophthalmopathy. Am J Ophthalmol 1995;119:792\u2013795.","journal-title":"Am J Ophthalmol"},{"key":"579_CR15","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s10384-005-0330-9","volume":"50","author":"H. Tsukamoto","year":"2006","unstructured":"Tsukamoto H, Mukai S, Iwase A, Mishima HK. Recovery of reliability by retest after a 5-minute interval in frequency doubling technology perimetry. Jpn J Ophthalmol 2006;50:380\u2013382.","journal-title":"Jpn J Ophthalmol"},{"key":"579_CR16","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1097\/00006324-199908000-00027","volume":"76","author":"C.W. Adams","year":"1999","unstructured":"Adams CW, Bullimore MA, Wall M, Fingeret M, Johnson CA. Normal aging effects for frequency doubling technology perimetry. Optom Vis Sci 1999;76:582\u2013587.","journal-title":"Optom Vis Sci"},{"key":"579_CR17","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0896-1549(03)00011-7","volume":"16","author":"A.J. Anderson","year":"2003","unstructured":"Anderson AJ, Johnson CA. Frequency-doubling technology perimetry. Ophthalmol Clin North Am 2003;16:213\u2013225.","journal-title":"Ophthalmol Clin North Am"},{"key":"579_CR18","first-page":"1783","volume":"41","author":"P.A. Sample","year":"2000","unstructured":"Sample PA, Bosworth CF, Blumenthal EZ, Girkin C, Weinreb RN. Visual function-specific perimetry for indirect comparison of different ganglion cell populations in glaucoma. Invest Ophthalmol Vis Sci 2000;41:1783\u20131790.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"579_CR19","first-page":"1","volume-title":"Clinical epidemiology","author":"D.L. Sackett","year":"1991","unstructured":"Sackett DL, Haynes RB, Gyatt GH, Tugwell P. Clinical epidemiology. Houston: Little, Brown & Company; 1991. p. 1\u2013441."},{"key":"579_CR20","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1001\/archopht.1981.03930010807002","volume":"99","author":"J.S. Kennerdell","year":"1981","unstructured":"Kennerdell JS, Rosenbaum AE, El-Hoshy MH. Apical optic nerve compression of dysthyroid optic neuropathy on computed tomography. Arch Ophthalmol 1981;99:807\u2013809.","journal-title":"Arch Ophthalmol"},{"key":"579_CR21","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1001\/archopht.1978.03910060033007","volume":"96","author":"J.D. Trobe","year":"1978","unstructured":"Trobe JD, Glaser JS, Laflamme P. Dysthyroid optic neuropathy. Clinical profile and rationale for management. Arch Ophthalmol 1978;96:1199\u20131209.","journal-title":"Arch Ophthalmol"},{"key":"579_CR22","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/eye.1994.159","volume":"8","author":"M.D. Tsaloumas","year":"1994","unstructured":"Tsaloumas MD, Good PA, Burdon MA, Misson GP. Flash and pattern visual evoked potentials in the diagnosis and monitoring of dysthyroid optic neuropathy. Eye 1994;8:638\u2013645.","journal-title":"Eye"},{"key":"579_CR23","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/BF00947007","volume":"235","author":"L. Spadea","year":"1997","unstructured":"Spadea L, Bianco G, Dragani T, Balestrazzi E. Early detection of P-VEP and PERG changes in ophthalmic Graves\u2019 disease. Graefes Arch Clin Exp Ophthalmol 1997;235:501\u2013505.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"579_CR24","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S0021-5155(03)00101-1","volume":"47","author":"G. Acaroglu","year":"2003","unstructured":"Acaroglu G, Simsek T, Ozalp S, Mutluay A. Subclinical optic neuropathy in Graves\u2019 orbitopathy. Jpn J Ophthalmol 2003;47:459\u2013462.","journal-title":"Jpn J Ophthalmol"},{"key":"579_CR25","first-page":"1027","volume":"82","author":"M. Salvi","year":"1997","unstructured":"Salvi M, Spaggiari E, Neri F, et al. The study of visual evoked potentials in patients with thyroid-associated ophthalmopathy identifies asymptomatic optic nerve involvement. J Clin Endocrinol Metab 1997;82:1027\u20131030.","journal-title":"J Clin Endocrinol Metab"},{"key":"579_CR26","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1023\/A:1022561530782","volume":"106","author":"G. Ambrosio","year":"2003","unstructured":"Ambrosio G, Ferrara G, Vitale R, De Marco R. Visual evoked potentials in patients with Graves\u2019 ophthalmopathy complicated by ocular hypertension and suspect glaucoma or dysthyroid optic neuropathy. Doc Ophthalmol 2003;106:99\u2013104.","journal-title":"Doc Ophthalmol"},{"key":"579_CR27","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1136\/bjo.2006.110932","volume":"91","author":"C.M. Dayan","year":"2007","unstructured":"Dayan CM, Dayan MR. Dysthyroid optic neuropathy: a clinical diagnosis or a definable entity? Br J Ophthalmol 2007;91:409\u2013410.","journal-title":"Br J Ophthalmol"},{"key":"579_CR28","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1136\/bjo.2006.094607","volume":"91","author":"D. McKeag","year":"2007","unstructured":"McKeag D, Lane C, Lazarus JH, et al. Clinical features of dysthyroid optic neuropathy: a European Group on Graves\u2019 Orbitopathy (EUGOGO) survey. Br J Ophthalmol 2007;91:455\u2013458.","journal-title":"Br J Ophthalmol"},{"key":"579_CR29","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/sj.eye.6700376","volume":"17","author":"K.C. Fong","year":"2003","unstructured":"Fong KC, Byles DB, Constable PH. Does frequency doubling technology perimetry reliably detect neurological visual field defects? Eye 2003;17:330\u2013333.","journal-title":"Eye"},{"key":"579_CR30","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1097\/01.opx.0000225912.06027.ac","volume":"83","author":"S.K. Gardiner","year":"2006","unstructured":"Gardiner SK, Anderson DR, Fingeret M, McSoley JJ, Johnson CA. Evaluation of decision rules for frequency-doubling technology screening tests. Optom Vis Sci 2006;83:432\u2013437.","journal-title":"Optom Vis Sci"},{"key":"579_CR31","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/j.1600-0420.2005.00423.x","volume":"83","author":"G.P. Heeg","year":"2005","unstructured":"Heeg GP, Blanksma LJ, Hardus PL, Jansonius NM. The Groningen Longitudinal Glaucoma Study. I. Baseline sensitivity and specificity of the frequency doubling perimeter and the GDx nerve fibre analyser. Acta Ophthalmol Scand 2005;83:46\u201352.","journal-title":"Acta Ophthalmol Scand"},{"key":"579_CR32","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1600-0420.2005.00424.x","volume":"83","author":"G.P. Heeg","year":"2005","unstructured":"Heeg GP, Stoutenbeek R, Jansonius NM. Strategies for improving the diagnostic specificity of the frequency doubling perimeter. Acta Ophthalmol Scand 2005;83:53\u201356.","journal-title":"Acta Ophthalmol Scand"},{"key":"579_CR33","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1136\/bjo.85.3.360","volume":"85","author":"R. Casson","year":"2001","unstructured":"Casson R, James B, Rubinstein A, Ali H. Clinical comparison of frequency doubling technology perimetry and Humphrey perimetry. Br J Ophthalmol 2001;85:360\u2013362.","journal-title":"Br J Ophthalmol"},{"key":"579_CR34","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1097\/01.ijg.0000184833.85912.2a","volume":"14","author":"P. Fogagnolo","year":"2005","unstructured":"Fogagnolo P, Mazzolani F, Rossetti L, Orzalesi N. Detecting glaucoma with frequency-doubling technology perimetry: a comparison between N-30 and C-20 screening programs. J Glaucoma 2005;14:485\u2013491.","journal-title":"J Glaucoma"},{"key":"579_CR35","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1034\/j.1600-0420.2003.00072.x","volume":"81","author":"L. Kalaboukhova","year":"2003","unstructured":"Kalaboukhova L, Lindblom B. Frequency doubling technology and high-pass resolution perimetry in glaucoma and ocular hypertension. Acta Ophthalmol Scand 2003;81:247\u2013252.","journal-title":"Acta Ophthalmol Scand"}],"container-title":["Japanese Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-008-0579-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10384-008-0579-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-008-0579-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-008-0579-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T16:20:23Z","timestamp":1559146823000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10384-008-0579-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["579"],"URL":"https:\/\/doi.org\/10.1007\/s10384-008-0579-x","relation":{},"ISSN":["0021-5155","1613-2246"],"issn-type":[{"value":"0021-5155","type":"print"},{"value":"1613-2246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}